5 SIMPLE STATEMENTS ABOUT HEMGENIX EXPLAINED

Number of eligible clients: CDEC talked over the uncertainty in the number of patients with reasonably extreme to critical hemophilia B in Canada suitable for etranacogene dezaparvovec. Clinical authorities consulted by CADTH indicated that some patients who will be categorised as possessing delicate or average illness could possibly have a severe